Skip to content
FIND A HEALTH VALLEY ACTOR

Spineart successfully raised a CHF20 Million convertible financing

Spineart-baguera

Spineart secures more than CHF 20 Million in convertible financing following completion of BAGUERA® C IDE studies enrolment.     The funding comes on the heels of the completion of enrolment in the two BAGUERA® C IDE studies, underlining Spineart’s commitment to advancing spinal surgery through large-scale investments in research and development. More than CHF…

Read More

Alithea Genomics closes CHF 2.8 Million in seed financing extension

Alithea-seed-extension

This milestone marks a significant step forward in the company’s journey to revolutionise large-scale RNA sequencing and transcriptomics.     Alithea Genomics, an emerging leader in the field of large-scale RNA sequencing and transcriptomics, announced today the closing of a CHF 2.8 million ($3.2 million) extension to its seed financing. The round was led by…

Read More

Artiria Medical, Planny and Algorized receive support from FIT

FIT-artiria-planny-algorized

The three startups have received financial support from the Foundation for technological innovation (FIT). Artiria Medical gets a Tech Growth loan to treat strokes Artiria Medical, a leader in medical device innovation for neurovascular treatments, receives a CHF 500,000 Tech Growth Loan. Their unique deflectable wire technology, which significantly improves the accuracy and speed of…

Read More

Artiria Medical successfully secures USD 6 Million

Artiria Medical

Artiria Medical secures funding to complete its clinical studies in stroke in both Europe and the Us, following promising first in-human results and FDA clearance.     The MedTech company, developing next-generation neuro-interventional products for stroke and aneurysms, successfully closed off a Series A2 round of USD 0.6 Million. Furthermore, they secured an additional USD…

Read More

Argá Medtech SA closes oversubscribed Series B

ArgaMedtech-series b

Argá Medtech announces €54 Million oversubscribed series B capital raise.     The round was led by the existing investors, Advent Life Sciences (UK) and Earlybird Health (Germany), as well as new investor Gilde Healthcare (the Netherlands) and an undisclosed strategic investor. The financing enables Argá Medtech to advance the development of its innovative CSE™…

Read More

Alys Pharmaceuticals launches with $100 Million financing from Medicxi

Alys Pharmaceuticals

Formed through the aggregation of six-asset centric Medicxi companies, including Aldena Therapeutics, Alys boasts a robust R&D pipeline of cutting-edge programmes and platforms targeting multiple dermatological indications.     Co-founded by Medicxi and several world-leading dermatology and scientific experts, Alys is a Boston and Geneva-based cutting edge pure-play immuno-dermatology company. It combines the assets and…

Read More

Pfizer Research Prize: 3 Researchers From The Swiss Health Valley Awarded

Pfizer Foundation Prize

13 young researchers from Fribourg, Geneva, Basel, Bern, and Zurich have won a 2024 Pfizer Research Award.   Since 1992, Pfizer Prize for Research has been awarded annually to young scientists conducting research at Swiss research institutes or hospitals. The award, is aimed at outstanding and pioneering contributions in pure and clinical research. Each awarded…

Read More

4 life sciences projects supported by the FIF

Fongit Innovation Fund

Four Geneva-based technology projects have won funding from the Fongit Innovation Fund (FIF) for their innovations. A seed loan of CHF 100,000 has been granted to Carrat Sàrl. Three grants of CHF 50,000 have been awarded to each of the following: iSleep, LaxiPed and Pneumoscope.     Seed loan of CHF 100,000 awarded to Carrat…

Read More

Impossible Materials wins the Mass Challenge Diamond Prize

Mass Challenge Award 2023

The University of Fribourg chemtech spin-off has been granted CHF 120,000 in cash. The start-up provides cellulose white pigment solutions to enable businesses greener product formulations.     In April, the start-up raised CHF 3.4 million to work on marketing its first product, a cellulose-based white pigment. The product is positioned as an alternative to…

Read More

Emovo Care receives a CHF 100’000 FIT loan

Emovo Care

The FIT (Fondation pour l’Innovation Technologique) in Canton of Vaud supports Emovo Care with a FIT Tech Seed loans of CHF 100’000     Emovo Care isL spin-off. The start-up is at the forefront of medical technology with its innovative hand exoskeleton tailored for patients suffering from neurological or orthopaedic injuries. This groundbreaking device will…

Read More